Battling the virus: Most of SA’s 31 million J&J vaccines to be produced locally

Share your Subscriber Article
You have 5 articles to share every month. Send this story to a friend!
0:00
play article
Subscribers can listen to this article
President Cyril Ramaphosa and Deputy President David Mabuza during an oversight visit to Aspen Pharmacare's sterile facility in Gqeberha on Monday, 29 March. Photo - GCIS
President Cyril Ramaphosa and Deputy President David Mabuza during an oversight visit to Aspen Pharmacare's sterile facility in Gqeberha on Monday, 29 March. Photo - GCIS

Most of the country's 31 million Johnson & Johnson Covid-19 vaccines, set to be rolled out in the coming months, will be locally compounded, packed and filled by Aspen Pharmacare at its sterile manufacturing plant in Gqeberha.

While some doses will still be exported, commitments have been given that 250 million doses will also be earmarked for Africa. But the single-shot vaccine, shown to be effective against the locally discovered B1.351 variant, has long been considered the country's best hope for widespread vaccination.

There’s more to this story
Subscribe to News24 and get access to our exclusive journalism and features today.
Subscribe
Already a subscriber? Sign in
Lockdown For
DAYS
HRS
MINS
Voting Booth
Would you choose to continue working from home after the coronavirus lockdown if given the option?
Please select an option Oops! Something went wrong, please try again later.
Results
Yes, it's much better for me
40% - 6589 votes
No ways! I can't wait to get back to the office
12% - 1934 votes
A mixture of both would suit me best
48% - 7928 votes
Vote
USD/ZAR
14.61
(0.0)
GBP/ZAR
20.02
(0.0)
EUR/ZAR
17.37
(0.0)
AUD/ZAR
11.13
(0.0)
JPY/ZAR
0.13
(0.0)
Gold
1,743.98
(0.0)
Silver
25.25
(0.0)
Platinum
1,204.50
(0.0)
Brent Crude
62.95
(-0.4)
Palladium
2,641.93
(0.0)
All Share
67,191
(+0.2)
Top 40
61,459
(+0.3)
Financial 15
12,123
(+0.8)
Industrial 25
87,544
(+0.1)
Resource 10
68,608
(+0.2)
All JSE data delayed by at least 15 minutes Iress logo